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Resting B cells can be cultured to induce antibody-secreting cell (ASC) differentiation in 
vitro. A quantitative analysis of cell behavior during such a culture allows the influences of 
different stimuli and gene products to be measured. The application of this analytical system 
revealed that the OBF-1 transcriptional coactivator, whose loss impairs antibody production 
in vivo, has two effects on ASC development. Although OBF-1 represses early T cell–
dependent (TD) differentiation, it is also critical for the completion of the final stages of 
ASC development. Under these conditions, the loss of OBF-1 blocks the genetic program of 
ASC differentiation so that 
 
Blimp-1/prdm1
 
 induction fails, and 
 
bcl-6
 
,
 
 Pax5
 
, and 
 
AID
 
 are not 
repressed as in control ASC. Retroviral complementation confirmed that OBF-1 was the 
critical entity. Surprisingly, when cells were cultured in lipopolysaccharide to mimic T cell–
independent conditions, 
 
OBF-1–null
 
 B cells differentiated normally to ASC. In the 
 
OBF-1
 
 
 
/
 
 
 
 
ASC generated under either culture regimen, antibody production was normal or only 
modestly reduced, revealing that Ig genes are not directly dependent on OBF-1 for their 
expression. The differential requirement for OBF-1 in TD ASC generation was confirmed in 
vivo. These studies define a new regulatory role for OBF-1 in determining the cell-
autonomous capacity of B cells to undergo terminal differentiation in response to different 
immunological signals.
 
Antibody-secreting plasma cells represent the
culmination of the B cell differentiation pro-
gram, which is a multistep process that is tightly
regulated by both extrinsic and intrinsic factors.
Because serum antibody arises from complex
molecular and cellular interactions (migration,
cellular interactions, and cell-autonomous re-
sponses to receptor-mediated signals), it is often
difficult to determine the mechanism underly-
ing a functional defect. An important example
is the transcription factor OBF-1 (also known
as OCA-B or Bob.1; references 1, 2). OBF-1 is
a transcriptional coactivator that binds, with
Oct-1 or Oct-2, to the octamer DNA element
in the regulatory regions of B cell–restricted
target genes (2, 3). Such binding sites occur in
the promoters of most Ig variable region genes,
though mice lacking OBF-1 and/or Oct-2 ex-
hibit largely normal B cell development and
express normal levels of Ig on the surface of
peripheral B cells (4–8). In vivo studies of
 
OBF-1–null
 
 mice revealed that B cell numbers
in peripheral lymphoid organs were near nor-
mal, but that humoral responses to the antigen
were severely diminished; this was particularly
evident for the Ig of switched isotypes (5–7).
 
OBF-1–null
 
 mice lack both germinal centers
(GCs) and marginal zone B cells, and they have
a paucity of fully mature B cells in the periphery
(9, 10), which implies that OBF-1 has diverse
influences on B cell development.
Kim et al. (5) proposed that the poor anti-
body response of OBF-1–deficient mice was a
consequence of reduced Ig gene transcription
by an antibody-secreting cell (ASC) expressing
switched isotypes. Indirect effects have also
been suggested, as OBF-1 modulates the ex-
pression of the 
 
CXCR5
 
 gene that encodes the
receptor for CXCL13, which is a chemokine
that positions B cells in lymphoid follicles (11).
Furthermore, Casellas et al. (12) found that a
subset of Ig
 
 
 
 gene promoters were particularly
dependent on OBF-1 for efficient expression.
In the face of these manifold influences, the
precise mechanism underlying the poor hu-
moral response in 
 
OBF-1
 
 
 
/
 
 
 
 mice is unclear.
We recently developed a quantitative cul-
ture system for T cell–dependent (TD) B cell
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activation in vitro, leading to proliferation, isotype switch-
ing, and the generation of dividing, antibody-secreting
“plasmablast” cells (13, 14). Using this analytical system, cell
behavior can be monitored in relation to the cell division
number, and even subtle changes in differentiation rates,
proliferation, or survival can be measured. The ability to
measure multiple properties simultaneously and quantita-
tively provides a powerful tool for identifying B cell–intrin-
sic defects arising from genetic alterations. We applied this
analysis to B cells lacking OBF-1 and revealed a critical role
for this factor in division-linked ASC differentiation. OBF-1
deletion was found, paradoxically, to accelerate the initial
rate of B cell differentiation while blocking the final stages of
ASC development. OBF-1 was found to lie upstream of
 
Blimp-1/prdm1
 
, an essential regulator of ASC differentiation,
during T cell–driven ASC differentiation in vitro and in
vivo. In contrast, OBF-1 was found to be dispensable for
ASC differentiation induced in vitro or in vivo using LPS, a
T cell–independent B cell activator. These results give novel
insights into the role of OBF-1 in determining serum Ig lev-
els and serve to illustrate how quantitative in vitro methods
may prove useful for exploring the mechanisms of action of
other B cell function regulators.
 
RESULTS
OBF-1–deficient B cells display a cell-autonomous 
defect in antibody production
 
OBF-1
 
 
 
/
 
 
 
 mice, both naive and immunized, display abnor-
mally low levels of serum Ig. IgM levels are modestly re-
duced, whereas Ig levels of switched isotypes such as IgG1
are markedly lower (5–8). As the absence of GCs in OBF-1–
null mice (5–7) would have a strong indirect influence on Ig
titers in vivo, we wanted to determine the intrinsic anti-
body-producing capacity of 
 
OBF-1–null
 
 B cells in our model
system of TD ASC differentiation (14). To do this, we puri-
fied small resting 
 
OBF-1–null
 
 B cells, cultured them in the
presence of the T cell stimuli CD40L and IL-4, and mea-
sured the Ig secreted into the medium over 7 d. B cells from
similarly purified C57BL/6 (B6) control mice were used as
controls. Representative data, shown in Fig. 1 A, indicate
that IgM and IgG1 production were differentially affected by
the loss of OBF-1 (reduced by 3.6 
 
 
 
 2.5-fold and 38.9 
 
 
 
11.8-fold, respectively; mean 
 
  
 
SD
 
 
 
of five determinations).
IgE is also produced under these conditions and was reduced
in 
 
OBF-1
 
 
 
/
 
 
 
, compared with control cultures, by 38- and
49-fold in two independent assessments. Therefore, OBF-1–
deficient B cells have an intrinsically reduced capacity to
produce Ig in response to T cell–derived signals when cul-
tured under optimal conditions, and switched isotypes are
most strongly affected.
 
OBF-1 is required for normal ASC differentiation in vitro
 
B cells cultured in CD40L/IL-4 over several days differenti-
ate to dividing ASC (plasmablasts) that express high levels of
the surface marker Syndecan-1 (14). ASC generated in vivo,
or produced in vitro under other culture conditions, can be
polymorphic with respect to their Syndecan-1 expression
(15, 16). However, we found that all antibody-secreting
functions lie within the Syndecan-1
 
hi
 
 population of CD40L/
Figure 1. OBF-1 is required for normal ASC differentiation. (A) Ig 
levels in day 7 culture supernatants of small resting B cells, purified and 
pooled from four B6 or OBF-1 /  mice, stimulated with CD40L/IL-4. Data 
from two independent experiments are shown (shaded bars, B6; open bars, 
OBF-1 / ). (B) B cells prepared, CFSE labeled, and cultured as described pre-
viously (14) were harvested after 4 d and stained for Syndecan-1 expression. 
Histograms demonstrate the CFSE profile (top) and the dot plots show 
Syndecan-1 expression. (C) Graph showing the proportion of cells present in 
each cell division peak that was Syndecan-1  at day 4 of the culture (as in 
B; open circles, B6; closed squares, OBF-1 / ). (D) Graph showing the pro-
portion of IgG1  cells present in each cell division peak at day 4 of the cul-
ture (as in B). (E) Graph showing the proportion of live cells present in each 
cell division peak at days 3 and 4 of the culture (as in B). (F) The cell division 
linked differentiation of Syndecan-1  cells to Syndecan-1int and Syndecan-1hi 
cells by control B6 B cells. CFSE-labeled B6 B cells were cultured for 3 d, and 
then stained for Syndecan-1 expression. Cells from division 3 were sorted by 
Syndecan-1 level (high, int, and low; left, boxes indicate sorting gates and 
include the percentage of cells in each sorting gate). Postsort purity is 
shown by the dotted line histograms (right). Cells were returned to the cul-
ture for a further 26 h and restained for Syndecan-1 (continuous line histo-
grams). (G) B cells were stained after 4 d of CD40L/IL-4 stimulation and 
sorted on the basis of Syndecan-1 expression (left, sorting gates shown as 
boxes). There is no stain in the x axis channel, but the gain is set to enable 
easy visualization of rare Syndecan-1hi cells. Cells were recultured in the 
absence of mitogens and cytokines. The antibody-secreting capacity of the 
cells, based on the Syndecan-1 level, was determined. Ig secreted into super-
natant by 2,000 sorted cells during 4 h of culture is shown ([right] shaded 
bars, B6; open bars, OBF-1 / ). Values are mean   SD of triplicate cultures. 
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IL-4 cultures and have used this marker here to identify ASC
generated in vitro. Functional confirmation was performed
in parallel (Fig. 1 F).
The poor antibody yield from 
 
OBF-1
 
 
 
/
 
 
 
 cell cultures
suggested that OBF-1 is required either for B cells to differ-
entiate to ASC under these conditions, or for the ASC gener-
ated to secrete normal amounts of antibody. To monitor the
rate of proliferation and the development of ASC per divi-
sion, B6 and 
 
OBF-1
 
 
 
/
 
 
 
 B cells were labeled with the cell di-
vision–tracking dye carboxyfluorescein diacetate succinimidyl
ester (CFSE) and cultured with CD40L/IL-4. Cells were
harvested after 4 d and analyzed for Syndecan-1 expression.
The CFSE histograms show that cells in both cultures prolif-
erated strongly (Fig. 1 B, top). Although control cultures
yielded significant numbers of Syndecan-1
 
hi
 
 cells in later divi-
sions, there was a clear deficit in the 
 
OBF-1
 
 
 
/
 
 
 
 cultures of
the Syndecan-1
 
hi
 
 cells that marked the ASC population (Fig.
1 B, bottom). Instead, cells expressing an intermediate level
of Syndecan-1 were found in markedly increased numbers
(Fig. 1 C). The proportion of isotype-switched cells per divi-
sion was similar in both cultures (Fig. 1 D); however, the de-
velopment of both IgM
 
 
 
 and isotype-switched IgG1
 
 
 
 Syn-
decan-1
 
hi
 
 ASC was blocked as a result of the 
 
OBF-1
 
mutation (not depicted). The cell survival and average divi-
sion profiles of control and mutant B cells were identical on
day 3 of the culture (Fig. 1 E and not depicted), but by day 4,
control cultures contained a slightly higher number of cells in
later divisions. We recently demonstrated that Syndecan-1
 
hi
 
plasmablasts, which arise in later divisions, divide more rap-
idly than undifferentiated B cell blasts (14). This would con-
tribute to the difference in division profiles on day 4.
We were interested in the derivation of cells that bore an
intermediate level of the ASC marker Syndecan-1 (Fig. 1 B).
Therefore, we subjected normal mouse B cells to a kinetic
analysis and monitored the fate of the Syndecan-1 marker.
B6 B cells were purified, CFSE labeled, and cultured as de-
scribed previously (13, 14). After 3 d, cells from a single cell
division were sorted by their Syndecan-1 levels (Fig. 1 F)
and returned to culture. After 24 h, cells were reanalyzed for
Syndecan-1 expression. We found no evidence for the shed-
ding or internalization of surface Syndecan-1, as expression
at 6 h was equal to or higher than the level at the time of
sorting (not depicted). The Syndecan-1
 
hi
 
 cells remained sta-
ble after 26 h and many Syndecan-1
 
int
 
 cells had become Syn-
decan-1
 
hi
 
, whereas some Syndecan-1
 
lo
 
 cells became Synde-
can-1
 
int
 
, which was consistent with a progression towards
the increased expression of this marker.
We determined the antibody-producing capacity of cells
sorted by Syndecan-1 level to confirm that only the Synde-
can-1
 
hi
 
 cells were ASC and to directly measure the require-
ment for OBF-1 in antibody production by preformed
plasma cells. The loss of OBF-1 dramatically reduces the
number of Syndecan-1
 
hi
 
 cells produced in culture, but rare
Syndecan-1
 
hi
 
 cells are generated in 
 
OBF-1
 
 
 
/
 
 
 
 cultures. B6
and 
 
OBF-1–null
 
 B cells, cultured for 4 d in CD40L/IL-4,
were sorted into low, intermediate, and high Syndecan-1
populations (Fig. 1 F). Equal numbers of each were cultured
for a further 4 h in the absence of stimuli. ASC activity in
each culture was determined using ELISA to measure the
amount of antibody secreted during this time. Only the Syn-
decan-1
 
hi
 
 cells secreted antibody effectively, regardless of ge-
notype (Fig. 1 F). 
 
OBF-1–null
 
, Syndecan-1
 
hi
 
 ASCs secreted
almost normal levels of IgM. In contrast, IgG1 secretion was
reproducibly reduced in the 
 
OBF-1
 
 
 
/
 
 
 
 cultures compared
with controls. Collectively, these data show that OBF-1 is
required for efficient ASC differentiation under TD condi-
tions, but it is dispensable for IgM production by terminally
differentiated ASCs. However, optimal IgG1 production
from ASCs requires OBF-1, which is consistent with previ-
ous results (5).
 
OBF-1 regulates the rate of ASC differentiation
 
We previously showed that Syndecan-1
 
hi
 
 ASCs are gener-
ated in this culture system at an increasing frequency with
Figure 2. Accelerated differentiation of OBF-1 /  B cells. (A) Com-
parison of differentiation rates for B6 and OBF-1 /  B cells. CFSE-labeled B 
cells were cultured with CD40L/IL-4 for 3 d, and then stained for Syndecan-1 
expression. Syndecan-1  cells sorted from divisions 2, 3, 4, and 5 are 
shown. Postsort purity is shown (top). Cells were returned to culture for a 
further 26 h and restained for Syndecan-1 (bottom). The percentages of 
cells in the indicated regions are given. Note that Syndecan-1hi cells 
largely fail to form in the OBF-1 /  cultures. (B) Quantitative summary of 
the differentiation depicted in the contour plots of A. The percentage of 
Syndecan-1  cells that became Syndecan-1  during 26 h of culture after 
sorting each cell division peak is shown. 
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successive divisions (14), and Fig. 1 F shows that cells pass
through a Syndecan-1
 
int
 
 phase during this differentiation.
The higher proportion of Syndecan-1
 
int
 
 cells in 
 
OBF-1
 
 
 
/
 
 
 
cultures (Fig. 1, B and C) suggested that this process is initi-
ated more rapidly in cells lacking OBF-1, but the data might
also be explained by the preferential growth or survival of
 
OBF-1
 
 
 
/
 
 
 
 Syndecan-1
 
int
 
 cells. To directly assess whether
OBF-1 loss alters the rate of generation of Syndecan-1
 
int
 
from Syndecan-1
 
 
 
 cells, using the division number as a ref-
erence, control and mutant B cells were purified, CFSE la-
beled, and cultured. On day 3, individual cell division peaks
were sorted. Syndecan-1
 
 
 
 cells from each cell division were
purified (Fig. 2 A, postsort plots) and placed back into the
culture (with CD40L/IL-4) for a further 26 h. Although
control cells differentiated to Syndecan-1
 
int
 
 and then to Syn-
decan-1
 
hi
 
 cells, 
 
OBF-1
 
 
 
/
 
 
 
 B cells differentiated to Syndecan-
1
 
int
 
 cells much more rapidly per division than control B cells
(Fig. 2, A and B), implying that a normal function of OBF-1
is to restrict this transition. There was little progression of
 
OBF-1
 
 
 
/
 
 
 
 cells to the Syndecan-1
 
hi
 
 state, confirming a sec-
ond critical role for OBF-1 in the differentiation of Synde-
can-1
 
hi
 
 ASC in this system.
We examined the cell-surface phenotypes of 
 
OBF-1
 
 / 
and heterozygous control cells in more detail, staining simul-
taneously for Syndecan-1 and other markers known to
change during ASC differentiation. In control cultures, Syn-
decan-1hi ASC lost the expression of CD25, Fas, and Fc RII,
but Syndecan-1int cells retained these markers (Fig. 3 A). Syn-
decan-1int cells in OBF-1 /  cultures displayed a similar phe-
notype. When freshly isolated splenic B cells from naive mice
were examined, few B6 control cells expressed Syndecan-1,
but a significant proportion of OBF-1–null B cells bore an in-
termediate level of this marker. Staining for IgD confirmed
that the Syndecan-1int cells were mature and not pre–B cells
(Fig. 3 B). This suggests that Syndecan-1int cells are generated
more readily in vivo in OBF-1 /  mice because they are in
the in vitro system. We propose that Syndecan-1 levels cells
rise incrementally during ASC differentiation and that the loss
of OBF-1 blocks the acquisition of the high Syndecan-1 lev-
els that reflect terminal differentiation.
The  OBF-1 /  mice used here were generated on a
129/Sv mouse background (7) and were backcrossed several
generations to the B6 strain. Both 129/Sv and B6 B cells dif-
ferentiated readily to Syndecan-1hi ASC in our culture sys-
tem (Fig. 3 C and not depicted). Furthermore, serum Ig lev-
els in 129/Sv mice were comparable to those of B6 mice
(17). Finally, the ASC differentiation defect persists in ninth
generation backcross animals (unpublished data). Thus, the
ASC differentiation block we observed in OBF-1 /  B cells
is not linked to the genetic background of the mice. Collec-
tively, the results show that the differentiation of B cells to
the Syndecan-1hi plasmablast stage, in response to CD40L
and IL-4 signaling, depends critically on OBF-1 and its tar-
get gene(s).
Isotype switching continues in Syndecan-1int cells and is 
independent of OBF-1
CD40L/IL-4–stimulated B cells undergo isotype switching
with an increasing frequency per division. However, once B
cells become committed to the ASC differentiation program
under these culture conditions, they no longer switch iso-
types, even though they continue to divide (14). As Synde-
can-1int cells did not secrete antibody (Fig. 1 G), we assessed
their capacity to undergo isotype switching. IgG1  cells were
sorted by cell division peak (Syndecan-1  and Syndecan-1int)
from B6 and OBF-1 /  cultures (Fig. 4 A). After a reculture
period of 26 h, cells were labeled for surface IgG1 to assess
the isotype switching rate. Complete results are shown for
the sorted Syndecan-1  populations (Fig. 4 A), whereas re-
sults for the Syndecan-1int cells are shown only for the divi-
sion 5 sort (Fig. 4 B). We found no difference between the
isotype switching rates of control and OBF-1–null B cells; this
result agrees with Kim et al. (5), who also looked at isotype-
switched cells ex vivo. Interestingly, the switching rate of
Syndecan-1int cells was even higher than that of the Synde-
can-1  cells for both controls and mutants (Fig. 4 C), imply-
ing that these cells are not yet committed to becoming ASC.
Figure 3. Loss of OBF-1 blocks differentiation at a Syndecan-1int 
stage. (A) Comparison of the phenotypes of B cells cultured for 4 d in 
CD40L/IL-4. (B) Ex vivo staining of splenocytes from B6 and OBF-1–null 
mice. Syndecan-1 and IgD expression are shown. The percentage of cells 
in each quadrant is shown. (C) Analysis of the differentiation of day 4 
cultures of stimulated B cells from B6 and 129/Sv control mice, using 
Syndecan-1 surface staining on CFSE-labeled cells. The percentage of 
Syndecan-1hi cells is shown.JEM VOL. 201, May 2, 2005 1389
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Retroviral reconstitution of OBF-1 /  B cells restores ASC 
phenotype and function
It was possible that OBF-1 /  B cells performed aberrantly in
our culture system because they were not equivalent to B cells
from control mice, despite their normal proliferative responses
and isotype-switching capacity. To formally demonstrate that
the phenotype described in Figs. 1 and 2 could be attributed
directly to the absence of OBF-1, we restored the OBF-1 ex-
pression in primary OBF-1 /  B cells using retroviral-medi-
ated gene delivery and assessed the consequences in terms of
cell-surface phenotype and antibody-secreting functions.
B cells were infected one day after CD40L/IL-4 activa-
tion and monitored over 4 d. On day 2, neither the B6 nor
the OBF-1 /  cultures contained Syndecan-1hi cells (Fig. 5
A), but by day 4, such cells were evident in the control cul-
tures (Fig. 5 B). Both infected (GFP positive) and nonin-
fected control cells displayed similar differentiation proper-
ties, regardless of whether the retrovirus expressed OBF-1.
In OBF-1 /  cultures infected with the control vector, the
characteristic Syndecan-1int cells appeared by day 4, but few
Syndecan-1hi cells were present. Significantly, in OBF-1 / 
cultures infected with an OBF-1–expressing retrovirus, Syn-
decan-1hi cells appeared in the GFP  cell gate but not in the
uninfected cell gate (Fig. 5 B). These were primarily cells
that expressed the highest levels of GFP and, presumably, the
highest levels of OBF-1. If puromycin was included in the
cultures, there was an enrichment for infected cells to  90%
of viable cells by day 4 (Fig. 5, C and D). Here the Synde-
can-1hi cells were more clearly discernable and, in the OBF-
1 /  cultures, reached  60% of the number produced in
control cultures (Fig. 5 C). A Western blot analysis of puro-
mycin-selected cells showed that OBF-1 was expressed in
reconstituted  OBF-1 /  B cells, albeit at a significantly
lower level than endogenous OBF-1 (Fig. 5 D). Neverthe-
less, the level was sufficient enough to drive a considerable
proportion of cells to differentiate to the more mature Syn-
decan-1hi state.
In addition to the attainment of a differentiated surface
phenotype, the reconstituted OBF-1 /  B cells acquired an
increased capacity for antibody secretion (Fig. 5 E). Cells
from the puromycin-selected cultures at day 4 were har-
vested and washed, and equal numbers were returned to the
culture for another 18 h in a medium lacking stimuli. Ig se-
cretion by B6 control B cells was unaltered by infection with
either retrovirus, but IgM and, more dramatically, IgG1 pro-
duction was increased when OBF-1–null B cells were in-
fected with the OBF-1–expressing retrovirus (3–4-fold and
10–20-fold, respectively; Fig. 5 E). These studies confirm
that OBF-1 is necessary for the differentiation of B cells to
Syndecan-1hi ASC in this system.
Loss of OBF-1 disrupts the genetic program regulating 
ASC differentiation
We measured mRNA levels for genes that are differentially
regulated during ASC differentiation to discover whether
the loss of OBF-1 would affect their expression. CFSE-
labeled B6 and OBF-1 /  B cells were cultured in CD40L/
IL-4 for 4 d and sorted by their level of Syndecan-1 (the
gates used were similar to those shown in Fig. 1 B). Five
populations were recovered, including low, intermediate,
and high Syndecan-1 for B6, and low and intermediate Syn-
decan-1 for OBF-1 / . cDNA was prepared from sorted
cells and titrated to give equivalent  -actin signals on RT-
PCR. The data in Fig. 6 depict a representative experiment
Figure 4. In vitro isotype switching frequency by Syndecan-1  and 
Syndecan-1int cells is normal in the absence of OBF-1. (A) Cell division–
linked isotype switching from IgM to IgG1 in cells from CD40L/IL-4–
stimulated cultures is shown. IgG1 , Syndecan-1  cells were sorted by cell 
division number on day 3 and returned to culture (with complete medium) 
for an additional day. The percentage of cells that became IgG1  during 
this time is shown. (B) Same procedure as for A, but switching in sorted 
Syndecan-1int cells from division 5 only is shown. (C) Quantification of the 
rate of isotype switching. The percentage of cells from each division that 
had switched to IgG1 expression in the reculture period is graphed (open 
circle, B6 controls; closed squares, OBF-1 / ; continuous lines, switching 
rates for Syndecan-1 cells; dotted lines, data for Syndecan-1int cells).OBF-1 REGULATES IG-SECRETING CELL DIFFERENTIATION | Corcoran et al. 1390
(A) and the averages of normalized expression values from
several experiments (B).
Several genes behaved as expected in control B cells with
differentiation. Indeed, changes characteristic of ASC differ-
entiation were already apparent in the Syndecan-1int popula-
tion. Regulation of c-myc, CstF-64, a polyadenylation fac-
tor mediating the transition from membrane-bound to
secreted forms of IgH chains (18), and the transcription fac-
tor Xbp-1, a regulator of the unfolded protein response that
is essential for plasma cell development (19, 20), were not af-
fected by the loss of OBF-1. Strikingly, the gene encoding
Blimp-1, a key factor driving ASC differentiation (21), was
induced strongly in control cells, but was not induced in
OBF-1 /  cells (Fig. 6, A and B). Similarly, genes encoding
J chain—a mediator of polymeric IgM and IgA transport
(22)—the transcription factor IRF-4 (23, 24), and the CDK
inhibitor p18(INK4c), which is required for the generation
of functional plasma cells (25), required OBF-1 for full in-
duction (Fig. 6 and not depicted). When we looked at the
expression of mRNAs for the membrane-bound or secreted
isoforms of C  and C 1, the loss of OBF-1 dramatically re-
duced the level of the mRNA encoding secreted isoforms
only. Consistent with our kinetic assessment and previous
studies of isotype switching by OBF-1 /  B cells (5), the
levels of I 1 sterile transcripts were not affected by the loss
of OBF-1.
As expected from the existing model of ASC differentia-
tion (26), some genes were repressed during normal differ-
entiation in vitro (Fig. 6 A), including those encoding AID,
a mediator of somatic hypermutation and isotype switching
(27), Bcl-6, a repressor required for GC formation (28), and
Pax5, both a positive and negative regulator of genes in B
lineage cells (29). However, these genes were not repressed
in OBF-1 /  cells and were even expressed at somewhat
higher levels than in the controls. Together, these data reveal
an unexpected and critical role for OBF-1 in determining
the proper regulation of genes driving the terminal differen-
tiation of B cells to antibody-secreting plasma cells in vitro.
Even though the loss of OBF-1 severely restricted the
capacity of cells to differentiate to ASC under these condi-
tions, rare Syndecan-1hi ASC were reproducibly generated
(Fig. 1). When these cells were sorted and compared with
controls, the expression of genes required for ASC differen-
tiation, including Blimp-1, IRF-1, and J chain, appeared nor-
mal (Fig. 6 C), which is consistent with their antibody-
secreting capacities (Fig. 1 F). Therefore, OBF-1 is not
absolutely required for the ASC differentiation program of
gene expression to be elaborated in response to T cell signals,
but it dramatically improves the efficiency with which ASC
differentiation proceeds.
To confirm that OBF-1 is required for Blimp-1 expres-
sion during ASC differentiation, we made use of a novel
Figure 5. Reconstitution of OBF-1 expression restores ASC differ-
entiation to OBF-1 /  B cells. (A) CD40L/IL-4–activated B cells infected 
with a control (vector) or an OBF-1–expressing retrovirus (pOBF) are 
analyzed on day 2 after infection for Syndecan-1 expression. The boxes 
highlight Syndecan-1hi cells. Infected cells express GFP. (B) Analysis of the 
cultures on day 4, in the absence of drug selection. (C) Analysis of parallel 
day 4 cultures after puromycin selection. The cultures infected with the 
OBF-1–expressing retrovirus are shown, as is the percentage of live cells in 
the Syndecan-1 hi, GFP  gate. Note that only the brightest GFP  cells in B 
and C, which likely express the highest amounts of OBF-1, have differenti-
ated to Syndecan-1hi cells. (D) Histograms show the percentage of live 
cells that express GFP on day 4 of puromycin-containing cultures (left). 
B6/vec indicates B6 B cells infected with the control retroviral vector; 
OBF/pOBF indicates OBF-1 /  B cells infected with the OBF-1–expressing 
virus. Western blot analysis of OBF-1 and actin expression in puromycin-
selected cells on day 4 after infection (right). Marker sizes are in kiloDaltons. 
(E) ELISA assay on serial dilutions of 18-h culture supernatants of day 4 
puromycin-selected cells (circles, B6 B cells; squares, OBF-1 /  B cells). 
Open symbols indicate an infection with the control retrovirus and closed 
symbols indicate an infection with the OBF-1–expressing retrovirus.JEM VOL. 201, May 2, 2005 1391
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mouse strain that bears a GFP cDNA integrated into the en-
dogenous Blimp-1 locus to report Blimp-1 expression while
disabling the gene. In heterozygous mice, GFP faithfully re-
veals all ASC (16). We crossed this Blimpgfp/  mouse with the
OBF-1 /  strain to look for the influence of OBF-1 on the
expression of the endogenous Blimpgfp allele. B cells from
mice of all possible genotypes were purified, cultured in
CD40L/IL-4, and examined for differentiation to Synde-
can-1 , GFP  cells (Fig. 7 A). As homozygous Blimpgfp/gfp mice
died during gestation, B cells of this genotype were obtained
from  RAG-1 /  mice reconstituted with fetal liver stem
cells as previously described (4). An analysis of cultured cells
confirmed earlier findings that Blimp-1 expression is required
for differentiation to Syndecan-1hi ASC (30). It also con-
firmed the OBF-1 dependence of Blimp-1 expression. In-
deed,  Blimpgfp/gfp  and  OBF-1 /  B cells both seem to be
blocked at a Syndecan-1int state. A larger number of these
cells accumulated in the OBF-1 /  culture, which was con-
sistent with the accelerated differentiation we observed ear-
lier (Fig. 2). This indicates a role for OBF-1 at this stage of
development that is independent of Blimp-1. These data
confirm that OBF-1 is required for Blimp-1 expression in B
cells stimulated under conditions that mimic TD activation.
The Blimpgfp/  mouse model enabled us to test whether
OBF-1 is required during ASC differentiation induced un-
der other conditions and in vivo. We previously found that
stimulating control Blimpgfp/  B cells with LPS, a T cell–inde-
pendent B cell activator, induced ASC universally express-
ing GFP, but with heterogeneous Syndecan-1 levels (refer-
ence 16; Fig. 7 B). Strikingly, ASC differentiation occurred
normally in the absence of OBF-1 under these culture con-
ditions, as did switching to IgG3 (unpublished data). Indeed,
GFP  cells sorted from both control and OBF-1 /  cultures
secreted equal amounts of IgM during a short reculture pe-
riod, with GFP , Syndecan-1hi cells producing more Ig per
cell than GFP , Syndecan-1  cells. These studies show that
Figure 6. Gene expression changes in cells differentiating in vitro 
and the influence of OBF-1 loss. (A) Semiquantitative RT-PCR measuring 
the mRNA levels for  -actin, HPRT, OBF-1, and 11 other genes implicated in 
ASC differentiation or function. Serial titrations of cDNA ( ), and controls 
were prepared without reverse transcriptase ( ) from cells cultured and 
sorted on day 4 by their Syndecan-1 level. (B) Quantification and normal-
ization of RT-PCR products. The x axes represent increasing maturity (from 
Syndecan-1lo to intermediate and high). All values are expressed relative 
to the level in the B6 Syndecan-1lo population (set to 1.0) for each assay. 
Values are the means ( SD) of multiple measurements, including multiple 
PCR assays and template concentrations, at least two independent biological 
samples, and normalization using both  -actin and HPRT. (C) Same proce-
dure as in A, but sorted Syndecan-1hi cells are assessed.OBF-1 REGULATES IG-SECRETING CELL DIFFERENTIATION | Corcoran et al. 1392
ASC differentiation in response to a model T cell–indepen-
dent activator proceeds in the absence of OBF-1. Impor-
tantly, they reveal differential molecular requirements for
ASC differentiation induced through T cell–dependent and
–independent means
To confirm these findings, Blimpgfp/  mice that were ei-
ther heterozygous or homozygous for the OBF-1 mutation
were immunized with the T cell–independent antigen, LPS,
or with the TD antigen (4-hydroxy-3-nitrophenyl)acetyl
(NP)–KLH. Spleens of unimmunized control and OBF-1–
deficient mice contained small populations of ASCs (Blimp-
1/GFP  and Syndecan-1hi; Fig. 7 D). Although the pro-
portion of ASC remained unchanged 7d after NP-KLH
immunization, NP-specific IgG1 ASCs, as detected by
ELISPOT, were only generated in the control animals.
OBF-1 /  mice made almost no anti-NP IgG1 ASCs (Fig. 7
E). The vast majority of ASCs present at this time reside in
foci, as the GC reaction had not yet reached fruition (31).
When ASC numbers peaked 3 d after LPS immunization
(16), ASCs had nearly tripled in both control and OBF-1–
null spleens (Fig. 7 F). The majority of LPS-induced ASC in
both control and OBF-1 /  spleens expressed the interme-
diate level of Blimpgfp that is characteristic of newly gener-
ated, rapidly expanding plasmablasts (16). These studies ex-
tend our conclusions drawn from in vitro analyses, indicating
that OBF-1 is required specifically for ASC differentiation in
response to TD antigens both in vitro and in vivo.
DISCUSSION
Defining the specific influences of OBF-1 on late 
B cell differentiation
We have used a quantitative in vitro culture system (13, 14)
to examine B cells that lack OBF-1, a transcriptional regula-
tor that strongly influences antibody levels in vivo, and to es-
tablish the underlying cause of the low serum Ig levels in
OBF-1–null mice. Although B cells from OBF-1 /  mice
proliferated in response to CD40L/IL-4 to the same extent
as wild-type cells and displayed a normal rate of isotype
switching, they exhibited a significantly increased rate of dif-
ferentiation per division, which generated an unusually high
proportion of Syndecan-1int cells in culture and in vivo. We
propose that OBF-1 normally represses the division-based
rate of differentiation, thereby restraining the development
of the transitional Syndecan-1int cell. The basic helix-loop-
helix protein Mitf has recently been shown to serve a similar
role in B cells (32), and future studies will investigate a func-
tional relationship between these two factors. In addition to
this early role, OBF-1 is later required to promote ASC dif-
Figure 7. OBF-1 is required for ASC differentiation and the ex-
pression of a Blimp-1 reporter gene under T cell–dependent, but not 
T cell–independent conditions. (A) Syndecan-1 and GFP expression 
(reporting an endogenous Blimp-1 gene expression), in B cells cultured for 
4 d in CD40L/IL-4. Percentages of cells that have the phenotype of ASC 
(top right, Synthetic-1hi and GFP ) are shown. Genotypes are shown in 
each plot. (B) Analyzed as in A, but cells were stimulated with 20  g/ml 
LPS. Percentages of cells that have the phenotype of ASC (top right, 
Syndecan-1hi and GFP ) are shown. (C) Antibody secreted from 6,000 
Syndecan-1  or Syndecan-1hi cells (B, boxed regions) sorted from LPS cul-
tures of control (shaded bar) or OBF-1–deficient (open bar) cells during 6 h 
reculture without stimuli. (D) Syndecan-1 and GFP expression in spleno-
cytes from naive Blimpgfp/ /OBF-1 /  and Blimpgfp/ /OBF-1 /  mice (top). 
ASC (boxed) percentages are given. ELISPOT plate and count (mean   SD) 
of NP-specific IgG1 ASC among 10,000 splenocytes plated (bottom). 
(E) Same procedure as in D, but spleens were from mice immunized 7 d 
earlier with NP-KLH. (F) Same procedure as in D, but from mice immunized 
3 d earlier with LPS (top). The histograms are of GFP levels on ASCs (boxed, 
bottom). Dotted lines represent unimmunized mice and solid lines repre-
sent LPS-immunized mice.JEM VOL. 201, May 2, 2005 1393
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ferentiation in vitro to generate Syndecan-1hi cells character-
ized by high rates of Ig secretion. The differentiation block is
evident in both IgM  and isotype-switched cells. This re-
quirement for OBF-1 is manifest specifically in response to
CD40L and IL-4, but not LPS stimulation.
During the differentiation of ASC, a genetic hierarchy has
been described whereby two transcriptional repressors, Bcl-6
and Blimp-1, appear to be critical (26, 33, 34). Bcl-6 main-
tains the GC phenotype of cells, and Blimp-1 drives ASC dif-
ferentiation through the repression of genes such as Pax5. In
the model, Bcl-6 and Pax5 inhibit differentiation, allowing
sufficient time for affinity maturation and class switch recom-
bination to occur in response to antigen and T cell signals
(35, 36). Once the differentiating cell reaches some functional
sufficiency, the B cell receptor signals the MAPK-mediated
phosphorylation and degradation of Bcl-6 (37). Bcl-6 has
been shown to repress Blimp-1 expression (34, 38, 39), so that
once Bcl-6 is lost, Blimp-1 is derepressed and ASC differenti-
ation ensues. Blimp-1 repression of the bcl-6 and Pax5 pro-
moters ensures that the process is irreversible (33). OBF-1,
like Bcl-6 and Mitf, may be necessary for the inhibition of
differentiation that enables the GC reaction to proceed suc-
cessfully. This property may contribute to the lack of GC in
OBF-1 /  mice, but other OBF-1 activities, such as the reg-
ulation of B cell receptor–signaling components (PM and
LMC; unpublished data) would also contribute.
OBF-1 appears to play an important role in the fulfil-
ment of the ASC program through a dramatic effect on the
transcription of the Blimp-1 gene. Two nonconsensus oc-
tamer motifs are present in the Blimp-1 promoter, but we
could find no evidence for a direct effect of OBF-1 on
Blimp-1 transcription using EMSA and chromatin immuno-
precipitation (unpublished data). Nevertheless, in the ab-
sence of OBF-1, Blimp-1 is not expressed in vitro in re-
sponse to CD40L and IL-4. Consequently, genes normally
repressed by Blimp-1, including bcl-6, Pax5, and oct-2 (33),
are expressed at abnormally high levels in differentiating
OBF-1 /  cells. Similarly, the Pax5 target gene encoding
the J chain is not fully activated in OBF-1 / –Syndecan-1int
cells (Fig. 6), and AID, a presumptive Pax5 target (40), is
overexpressed, suggesting that affinity maturation may be af-
fected in maturing OBF-1 /  B cells.
The model of TD B cell differentiation (Fig. 8) indicates
the points at which OBF-1 appears to exert its influence.
OBF-1 regulates the rate of generation of Syndecan-1int
cells, but two scenarios may exist at later stages of differenti-
ation. In the first (Fig. 8, dashed arrow), Syndecan-1int cells
are a homogeneous group of cells that simultaneously exhibit
phenotypic and genetic features of both ASC and less differ-
entiated “GC-like” cells. OBF-1 restricts the differentiation
of these precursor cells, so that ASCs are not efficiently
made, and the blocked cells express an aberrant gene expres-
sion profile. We prefer a second scenario (Fig. 8, solid arrow)
in which the Syndecan-1int populations are developmentally
heterogeneous, with some cells already committed to ASC
differentiation (upregulating; e.g., Blimp-1, IRF-4, and mR-
NAs for secreted IgH chains), while others remain in a less
differentiated state that can undergo switching and somatic
hypermutation (e.g., expressing bcl-6, Pax5, or AID). The
loss of OBF-1 specifically influences the fate, or the survival,
of the committed ASC “precursor,” thus blocking differenti-
ation. Kinetic and single cell analyses should distinguish be-
tween these possibilities.
It is clear that the immune phenotypes of OBF-1 / 
mice and Blimp-1 /  mice are different, and that the impact
of Blimp-1 loss on ASC differentiation and antibody titers in
vivo is more severe (16, 30). ASC differentiation is univer-
sally Blimp-1 dependent, whereas it is OBF-1 dependent
only under particular circumstances. We have shown that
Blimp-1  ASCs are generated inefficiently in the absence of
OBF-1 in CD40L/IL-4 cultures and in vivo upon immuni-
zation with a TD antigen. In contrast, much of the IgM-
producing capacity of an animal is OBF-1 independent (5–7,
and this study). Thus, an effective TD response requires
OBF-1, both before involvement of the GC, and for the GC
reaction itself.
OBF-1 regulates antibody production indirectly, with only 
minor influences on Ig gene expression
Both in vitro and in vivo, OBF-1 loss results in decreased
antibody production, and IgG production is affected more
severely than IgM production. Several factors have been
proposed to modulate the types and final titers of Ig in the
serum of OBF-1 /  mice. For instance, because OBF-1 / 
mice lack GCs, they would be expected to lack high titers of
switched antibody isotypes and memory responses.
Our data suggest that the poor production of IgG1 by
OBF-1 /  B cells is inherent and is independent of the GC
setting. By examining the rare ASC produced in vitro from
OBF-1 /  B cells cultured with CD40L/IL-4, we found
that IgM production is OBF-1 independent, as secretion was
similar to controls. In contrast, IgG1 secretion was moder-
ately sensitive to OBF-1 loss. Consistent with this, the ec-
Figure 8. Model of OBF-1 regulation during T cell–induced B cell 
differentiation in vitro. The scheme depicts the differentiation of resting 
B cells under the influence of CD40L and IL-4, indicating points at which 
OBF-1 loss influences the process.OBF-1 REGULATES IG-SECRETING CELL DIFFERENTIATION | Corcoran et al. 1394
topic expression of OBF-1 enhanced IgM secretion from
OBF-1–null ASCs, but IgG1 secretion was even more dra-
matically improved (Fig. 5 E). Kim et al. (5) proposed a re-
quirement for OBF-1 in the transcription of switched forms
of IgH genes to explain the differential effects of OBF-1 de-
letion on isotype-switched antibodies and went on to show
that the 3  IgH enhancer was less active in OBF-1 /  cells
(41). Importantly, we found that OBF-1 is critical only for
TD Blimp-1 induction and ASC differentiation (Figs. 6 and
7), whereas a T cell–independent inducer of ASC differenti-
ation works through an OBF-1–independent pathway. The
differential requirement for OBF-1 would thereby severely,
but specifically, affect only a subset of antibody responses.
We have identified a new and important role for OBF-1
in the generation of antibodies. Further analysis of how OBF-1
both positively and negatively regulates key aspects of ASC
differentiation is underway. Our model for OBF-1 function
in late B cell differentiation is consistent with the poor hu-
moral responses of OBF-1 /  mice to viral infections (42), as
well as with the observation that the loss of OBF-1 prevents
the generation of autoantibodies and the SLE-like disease of
Aiolos-null mice (43). Conceivably, the loss of OBF-1 expres-
sion from some human B cell malignancies (44, 45) might re-
flect the importance of OBF-1 in mediating normal terminal
differentiation. Use of this in vitro model of cell behavior in
the context of isotype switching and ASC differentiation will
be extremely useful in the characterization of the abnormal
behavior of B cells from designed or spontaneous mouse mu-
tants, or from immunodeficient patients displaying aberrations
in the humoral arm of the immune response.
MATERIALS AND METHODS
Mice. OBF-1–deficient mice (7) and age- and sex-matched control
C57BL/6 and 129/SV mice were bred at the Walter and Eliza Hall Institute
of Medical Research (WEHI). Blimpgfp/  mice, generated and bred at
WEHI, have been described elsewhere (16). Animal studies were approved
by the Animal Ethics Committee of Royal Melbourne Hospital. Mice were
immunized, and ASCs were characterized and enumerated, by ELISPOT as
described previously (16).
Reagents and antibodies. Cell membranes expressing the murine ligand
for CD40 (CD40L) were prepared as previously described (46). Recombi-
nant mouse IL-4 was provided by R. Kastelein (DNAX Research Institute,
Palo Alto, CA). Biotinylated anti–mouse IgG1 (A85.1), anti–mouse Fas
(Jo2), anti–mouse CD25 (7D4), anti–mouse Fc RII (2.4G2), and PE-con-
jugated anti–Syndecan-1 antibody were purchased from BD Biosciences.
Mouse IgM-specific b.7.6 mAb was biotinylated using NHS-biotin pur-
chased from Sigma-Aldrich. Streptavidin-Tricolor (SA-TC) was purchased
from Caltag Laboratories. FITC-conjugated anti–mouse IgD (11-26c.2a)
was purchased from BD Biosciences.
Cell culture and flow cytometry. Small resting B cells were prepared and
labeled for division tracking with CFSE (Molecular Probes Inc.) as described
elsewhere (47, 48). B cells were cultured and labeled for flow cytometric analy-
sis as described previously (4, 14). The analysis was performed on FACScan or
LSR flow cytometers (Becton Dickinson) using CELLQuest (Becton Dickin-
son) or Flow-Jo (Tree Star Inc.) software. Cell sorting was performed on a
FACStar  (Becton Dickinson) or MoFlo (Cytomation Inc.) cytometer.
CFSE peaks were individually gated and the proportion of Ig- or Syn-
decan-1–positive cells within each division round was calculated as de-
scribed previously (49). In some experiments, the proportion of live cells
per culture was estimated by reference to a known number of CaliBRITE
beads (unlabeled; Becton Dickinson) run simultaneously with cells on flow
cytometer (13, 49).
ELISA. Small resting B cells were cultured at 2   105 cells/ml for 7 d, at
which time supernatants were harvested. For Syndecan-1–sorted cell popu-
lations, cells were returned to culture for the stated period, without mito-
gens, before harvesting supernatants. Goat anti–mouse IgM or IgG1 anti-
bodies to coat the plates and biotinylated goat anti–IgM or IgG1 antibodies
as a secondary detection step were purchased from Southern Biotechnology
Associates, Inc. Purified mouse monoclonal IgM (TEPC 183) and IgG1
(MOPC 21) purchased from Sigma-Aldrich were used for the quantitative
determination of Ig concentrations.
RT-PCR analysis of plasma cell markers. Semiquantitative RT-PCR
was performed on cDNA made from sorted cell populations as previously
described (14).
The following primers were used:  -actin, 5 -GTG GGC CGC TCT
AGG CAC CAA-3 , 3 -CTC TTT GAT GTC ACG CAC GAT TTC-5 ;
J chain, 5 -GTC TTC ACT GGG GAG TCC TAG CC-3 , 3 -GGG TGC
AAA TGG AGA GCC TCT AAG G-5 ; Blimp-1, 5 -CAT TCC TGT
CCC CAA CGC ATC AAC TG-3 , 3 -GGT GCC CAA GCA CCA AAG
TCA TAG C-5 ; xbp-1, 5 -GCT GGA GCA GCA AGT GGT GGA TTT
GG-3 , 3 -GGC TTC CAG CTT GGC TGA TGA GGT CC-5 ; AID, 5 -
CCG GCA CGT GGC TGA GTT T-3 , 3 -GAT GCG CCG AAG TTG
TCT GGT TAG-5 ; bcl-6, 5 -CAG CAC CTT CCT CTT CTC TGA
TGA GGA GCT CC-3 , 3 -CTG GCG GAG AGC CAG AGG CCT
GAA GGA TGC-5 ; Pax5, 5 -CCT ACC CTA TTG TCA CAG GCC-3 ,
3 -CCT CTG TCT GTC TCA GGG GGT T-5 ; CXCR5, 5 -CCA CTA
ACC CTG GAC ATG GGC TCC-3 , 3 -GGG CCT GCA GTA GCC
TGT GGA CC-5 ; c-myc, 5 -GAC CTC GAC TAC GAC TCC GTA
CAG CCC-3 , 3 -CAG GCT GGT GCT GTC TTT GCG CGC AGC
C-5 ; cstF-64, 5 -CCA CCT CTG ATG CAG ACC TCT ATC CAG
GGA GG-3 , 3 -CTG GGA TCT GCT GCC AAT GGT CCT CCT
CTC-5 ; irf-4, 5 -GAA GCC CCA AAG CCC TCA GTC GTT G-3 , 3 -
GGG GCA TGT AAT TAA ACC TTG TGT G-5 ; obf-1, 5 -CGG TGT
TGA CCT ATG CTT CTC CAC C-3 , 3 -GAG GGG CGC CTG GTG
CTC GGG ACC C-5 ; C -common, 5 -CCC ACA GCA TCC TGA
CTG TGA CAG AGG AG-3 ; C -membrane isoform, 3 -GAT GAA
GGT GGA GGC AGT GGT CCA CAG G-5 ; C -secreted isoform, 3 -
CAG GTG CCG CCT GTG TCA GAC ATG ATC AGG-5 ; C 1-com-
mon, 5 -CAC CAG GAC TGG CTC AAT GGC AAG GAG-3 ; C 1-
membrane isoform, 3 -GTC CTG GGC CTC AGC ACA GGT CTC
GTC C-5 ; C 1-secreted isoform, 3 -GTA GGA CCA GAG GGC TCC AAG
GAC AC-5 ; and I 1, 5 -AGC ACG CAT CTG TGG CCC TTC CAG
ATC T-3 , 3 -CAG GTC ACT GTC ACT GGC TCA GGG AAA T-5 .
Retroviral complementation and in vitro differentiation of primary
B cells. B cells were purified from red- and dead cell–depleted spleen cell
suspensions using anti–B220-coupled magnetic beads (Miltenyi Biotec) and
cultured for 18–24 h with 5  g/ml anti-CD40 antibody (FGK45.5) and
100 U/ml IL-4 (complete medium). Cells were then infected with retrovi-
ral supernatants using a modified spin infection protocol (50). Cells were
washed 1 d after infection, and a new complete medium was applied, with
or without 2  g/ml puromycin. Cells were monitored for GFP and Synde-
can-1 expression for another 3–4 d. Retroviral supernatants were prepared
from the Phoenix packing cell line (51) transfected (FuGENE 6; Roche Di-
agnostics) with the pMXpie retroviral vector (gift of D. Krebs, Walter and
Eliza Hall Institute, Parkville; Australia, reference 52), or with a vector en-
coding full-length murine OBF-1.
Western blot. Total cell lysates of puromycin-resistant (retrovirally in-
fected) B cells were prepared on day 4 of the culture and analyzed by West-
ern blot using a monoclonal antibody raised against the NH2-terminal 45JEM VOL. 201, May 2, 2005 1395
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amino acids of murine OBF-1. A goat antiactin antiserum (Santa Cruz Bio-
technology, Inc.) was used as a loading control.
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